Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Amplification Status: Clinical Validation in the Context of a Hybrid Capture-Based, Comprehensive Solid Tumor Genomic Profiling Assay.
Ross, Dara S
Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Amplification Status: Clinical Validation in the Context of a Hybrid Capture-Based, Comprehensive Solid Tumor Genomic Profiling Assay. [electronic resource] - The Journal of molecular diagnostics : JMD 03 2017 - 244-254 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1943-7811
10.1016/j.jmoldx.2016.09.010 doi
Biomarkers, Tumor
Computational Biology--methods
DNA Copy Number Variations
Gene Amplification
Genetic Testing--methods
Humans
Immunohistochemistry
Neoplasms--diagnosis
Receptor, ErbB-2--genetics
Reference Standards
Reproducibility of Results
Sensitivity and Specificity
Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Amplification Status: Clinical Validation in the Context of a Hybrid Capture-Based, Comprehensive Solid Tumor Genomic Profiling Assay. [electronic resource] - The Journal of molecular diagnostics : JMD 03 2017 - 244-254 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1943-7811
10.1016/j.jmoldx.2016.09.010 doi
Biomarkers, Tumor
Computational Biology--methods
DNA Copy Number Variations
Gene Amplification
Genetic Testing--methods
Humans
Immunohistochemistry
Neoplasms--diagnosis
Receptor, ErbB-2--genetics
Reference Standards
Reproducibility of Results
Sensitivity and Specificity